5181 - 5190 of 6258 Results
Title
Year
- The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson Disease2020OPENTitle: The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 8Start Page: 1878End Page: 1878Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9081878Best OA location URL: https://www.mdpi.com/2073-4409/9/8/1878/pdf?version=1597644425Citation Count: 6
- Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial2024OPENTitle: Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trialJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100248End Page: 100248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100248Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100248Citation Count: 0
- Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsy2022OPENTitle: Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 4Start Page: e0266405End Page: e0266405Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0266405Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0266405&type=printableCitation Count: 5
- Mechanisms of Alpha-Synuclein-Seeded Aggregation in Neurons Revealed by Fluorescence Lifetime Imaging2025OPENTitle: Mechanisms of Alpha-Synuclein-Seeded Aggregation in Neurons Revealed by Fluorescence Lifetime ImagingJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 16Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.5c00236Best OA location URL: https://doi.org/10.1021/acschemneuro.5c00236Citation Count: 0
- Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohort2025OPENTitle: Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00919-yBest OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/148945Citation Count: 0
-
OPENTitle: Activation of parkin by a molecular glueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41467-024-51889-3Best OA location URL: https://doi.org/10.1038/s41467-024-51889-3Citation Count: 9
-
OPENTitle: A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studiesJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 85Issue #:Start Page: 59End Page: 67.e6Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.annepidem.2023.04.019Best OA location URL: https://doi.org/10.1016/j.annepidem.2023.04.019Citation Count: 3
- Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’S2016OPENTitle: Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’SJournal Name: Personalized MedicinePublisher: Informa UK LimitedVol: 14Issue #: 1Start Page: 13End Page: 15Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/pme-2016-0087Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/pme-2016-0087Citation Count: 0
- Development of a simplified smell test to identify Parkinson’s disease using multiple cohorts, machine learning and item response theory2025OPENTitle: Development of a simplified smell test to identify Parkinson’s disease using multiple cohorts, machine learning and item response theoryJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00904-5Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/148944Citation Count: 1
- A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT gene2021OPENTitle: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT geneJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 106Issue #:Start Page: 343.e1End Page: 343.e8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.010Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.05.010Citation Count: 6